← Leaderboards
William W Tse
Case Western Reserve University
$996,277
Attributed
$2,988,832
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.2M · FY2022–25$2M$1.5M$1M$500K$0
'22
'23
'24
'25
Funding mix
By agency
NIH$2,988,832 · 1
By mechanism
R01$2,988,832 · 1
Top collaborators
- Gang Huang4 shared
- Shujun Liu4 shared
Most similar at Case Western Reserve University
Same institution · by research overlap
- Zheng-Rong Lu$13,267,567
- John James Letterio$5,630,711
- Kimberly Parker$329,928
- Eric D. Kodish$7,633,755
- William Schiemann$12,636,493
Others in their field
Other Rising Stars on “Gene Expression”
- Jason Dickens · Duke University$12,259,409
- Daofeng Li · Salk Institute For Biological Studies$9,887,266
- Suma Babu · Massachusetts General Hospital$9,298,517
- Sabrina Paganoni · Massachusetts General Hospital$9,298,517
- April Carson · University Of Mississippi Med Ctr$9,022,104
- Eileen Mary O'Reilly · Sloan-Kettering Inst Can Research$7,024,010
Research focus
Gene ExpressionGenesAdvanced DiseaseGain Of FunctionGene RepressionCd44 GeneCell GrowthCellsCancer PatientClinical BiomarkersBiological MarkersCritical PathwaysDemethylationDesignDifferential ExpressionDisease ProgressionDisease RemissionDrug MaintenanceDrug ResistanceDrug SensitivityEngraftmentEpitranscriptomicsCancer Stem CellGenetic Transcription
Grant awards (4)
Role of an Aberrant N6-Methyladenosine-LncRNA Axis in the Development and Maintenance of Drug Resistance through Regulating the Leukemia Stem Cell$1,206,321
R01 · FY2025 · CA
Role of an Aberrant N6-Methyladenosine-LncRNA Axis in the Development and Maintenance of Drug Resistance through Regulating the Leukemia Stem Cell$573,003
R01 · FY2024 · CA
Role of an Aberrant N6-Methyladenosine-LncRNA Axis in the Development and Maintenance of Drug Resistance through Regulating the Leukemia Stem Cell$591,097
R01 · FY2023 · CA
Role of an Aberrant N6-Methyladenosine-LncRNA Axis in the Development and Maintenance of Drug Resistance through Regulating the Leukemia Stem Cell$618,411
R01 · FY2022 · CA